Roivant Sciences (ROIV) Other Accumulated Expenses (2021 - 2026)

Roivant Sciences has reported Other Accumulated Expenses for 6 years, with the latest figure at $583000.0 in Q1 2026.

• For the quarter ending Q1 2026, Other Accumulated Expenses fell 50.09% year-over-year to $583000.0; the trailing twelve-month figure through Mar 2026 stood at $583000.0 (down 50.09% YoY), and the FY2026 full-year result was $583000.0, down 50.09% from the prior year.
• Other Accumulated Expenses for Q1 2026 stood at $583000.0, down from $10.2 million in the prior quarter.
• The five-year high for Other Accumulated Expenses was $76.3 million in Q1 2023, with the low at $583000.0 in Q1 2026.
• Historically, Other Accumulated Expenses has averaged $21.8 million across 5 years, with a median of $10.9 million in 2022.
• Annual changes were most pronounced in 2023 — Other Accumulated Expenses jumped 602.7% — and 2025, when it sank 97.38%.
• Roivant Sciences' Other Accumulated Expenses stood at $14.3 million in 2022, then surged by 204.87% to $43.6 million in 2023, then sank by 91.72% to $3.6 million in 2024, then jumped by 183.5% to $10.2 million in 2025, then plunged by 94.31% to $583000.0 in 2026.
• The last three Other Accumulated Expenses figures came in at $583000.0 (Q1 2026), $10.2 million (Q4 2025), and $1.5 million (Q3 2025), per Business Quant data.